Ozon Pharmaceuticals reported for 2025 under IFRS

Ozon Pharmaceuticals' net profit under IFRS for 2025 amounted to ₽6.2 billion, an increase of 34.8% compared to ₽4.6 billion in the previous year. Revenue increased by 23.4% to ₽31.6 billion against ₽25.6 billion a year earlier.